Global Acne Drugs Market: Overview
Acne is a common dermatological problem affecting numerous people globally. This problem is occurring due to abnormal hormone production and rise in androgen levels in men and estrogen levels in women. This level rise strikes on puberty and expands oil glands under the skin. This leads to high production of sebum, which breaks down cells in pores leading to bacterial invasion. Additionally, risks of developing acne are higher due to genetic reasons, stress level, menstruation, and humid climate.
The acne drugs market reports discuss the macroeconomic aspects, growth factors, trends, challenges, and opportunities. Additionally, it offers the in-depth competitive analysis along with details of key players. It offers company history, annual turnover, segmental share, SWOT analysis, mergers and acquisitions (M&A) activities, new product launches, and recent research and development (R&D).
Global Acne Drugs Market: Drivers and Restraints
The growing prevalence of acne and other dermatological condition mainly in teenagers and adults is fuelling the need for novel drugs and likely to propel the growth of the global acne drugs market. Additionally, growing adoption of skin care products to treat skin problems due to unhealthy urban lifestyle is fuelling the growth of the global acne drugs market.
However, failure of pivotal clinical trials is restraining the growth of the global acne drugs market. In addition, off-label usage of anti-acne drugs, which may cause to the serious diseases such as cancer, is hampering the growth of the acne drugs market. Furthermore, some adverse effects such as high blood pressure, nausea, and birth defects are restraining growth of the global acne drugs market. Nonetheless, growing-investing in research and development (R&D) activities coupled with growing approval of drugs are offering lucrative opportunities for growth of the global acne drugs market.
Global Acne Drugs Market: Geographical Analysis
On the basis of region, the acne drugs market could be segmented into North America, South America, Europe, Asia Pacific, and the Middle East and Africa. Of these regions, North America is expected to dominate the global market for acne drugs and is expected to remain dominant over the forecast period. This growth of the region is attributable to the growing adoption of acne drugs due to growing consciousness about personal aesthetics coupled with growing availability of drugs in the region. However, Asia Pacific region is expected to expand with higher CAGR owing to growing adoption of acne drugs. Growing awareness for appearance across the developing countries such as India and China is likely to propel growth of the market in the region.
Global Acne Drugs Market: Companies Mentioned
Some of the key players operating in the acne drugs market are Allergan Plc., Galderma S.A., Mayne Pharma Group Limited, Johnson & Johnson, and Mylan N.V. These companies are focusing on activities such as collaborations, partnerships, and mergers & acquisitions for gaining a profitable edge in the global acne drugs market.
Market segmentation based on geography:
- North America
- South America
- Asia Pacific
- Middle East and Africa
This report gives access to decisive data, such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report include:
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments